Okay, let's tackle this question. The question is about which antipsychotic medication is not associated with weight gain. The options aren't provided, so I'll have to assume some common ones. First, I need to recall which antipsychotics are known for causing weight gain and which aren't.

Common antipsychotics that cause weight gain include olanzapine, clozapine, and quetiapine. These are second-generation (atypical) antipsychotics. They affect serotonin and dopamine receptors, leading to increased appetite and metabolic changes. Aripiprazole and ziprasidone are less likely to cause weight gain. Aripiprazole is a partial agonist at dopamine D2 receptors, which might explain its lower weight gain profile. Ziprasidone also has a lower risk, possibly due to its different receptor interactions.

So, the correct answer would be either aripiprazole or ziprasidone. If the options include one of these, that's the exception. Let's say the options are A. Olanzapine, B. Clozapine, C. Aripiprazole, D. Quetiapine. Then the correct answer is C. Aripiprazole.

Now, explaining why others are wrong. Olanzapine and clozapine are high in weight gain risk. Quetiapine is moderate. Aripiprazole is low. Need to mention the mechanisms: 5HT2A and H1 receptor antagonism in the others, while aripiprazole's partial agonism. Also, note that ziprasidone has lower risk but higher risk of other side effects like QT prolongation.

Clinical pearl: Remember that atypical antipsychotics vary in metabolic side effects. Aripiprazole is the least likely to cause weight gain. Mnemonic: "Aripa" (A for Avoid weight gain).

**Core Concept**
Antipsychotic medications vary in their metabolic side effect profiles. Weight gain is commonly associated with **serotonin 5-HT2A and histamine H1 receptor antagonism**, while **dopamine D2 antagonism** and **muscarinic M3 receptor blockade** also contribute. Atypical antipsychotics like olanzapine and clozapine have high weight gain risk, whereas aripiprazole and ziprasidone are exceptions.

**Why the Correct Answer is Right**
**Aripiprazole** is a **dopamine D2 partial agonist** and **serotonin 5-HT1A agonist/5-HT2A antagonist**. Its unique mechanism avoids full receptor blockade, reducing appetite stimulation and metabolic disruption. It lacks significant H1 or M3 antagonism, minimizing weight gain compared to other atypicals.

**Why Each Wrong Option is Incorrect**
**Option A: Olanzapine** – Causes profound weight gain via 5-HT2A, H1, and M3 antagonism.
**Option B: Clozapine** – Highly associated with weight gain due to 5-HT2A, H1, and D2 blockade.
**Option D: Quetiapine** – Moderate weight gain risk via 5-HT2A and H1 antagonism.

**Clinical Pearl / High-Yield Fact**
**"Aripa avoids the paunch"**

✓ Correct Answer: D. Molindone